Literature DB >> 20176857

Quantitative validation and comparison of multiplex cytokine kits.

Joanna L Richens1, Richard A Urbanowicz, Rebecca Metcalf, Jonathan Corne, Paul O'Shea, Lucy Fairclough.   

Abstract

The focus of biomarker studies is shifting toward deciphering patterns of biomolecules as they provide a more comprehensive depiction of disease than individual biomarkers. Multiplexing technologies are crucial in deciphering such patterns, but it is essential that they are validated for reproducibility and precision to ensure accurate protein identification. Here the authors examine such properties in Cytokine Bead Array (CBA) and Luminex kits and compare concentration measurements to those obtained using enzyme-linked immunosorbent assay (ELISA). Luminex kits were found to be highly reproducible and reliable; however, CBA kits were not due to aberrant standards. Absolute cytokine concentrations were dependent on the detection kit, but correlations with ELISA were good for all technologies.

Mesh:

Substances:

Year:  2010        PMID: 20176857     DOI: 10.1177/1087057110362099

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  36 in total

1.  Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Michael D Ludwig; Ian S Zagon; Patricia J McLaughlin
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-07

2.  Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples.

Authors:  J A Bastarache; T Koyama; N E Wickersham; L B Ware
Journal:  J Immunol Methods       Date:  2014-04-21       Impact factor: 2.303

3.  IL-1Rahigh-IL-4low-IL-13low: A Novel Plasma Cytokine Signature Associated with Olfactory Dysfunction in Older US Adults.

Authors:  Eli P Darnell; Kristen E Wroblewski; Kristina L Pagel; David W Kern; Martha K McClintock; Jayant M Pinto
Journal:  Chem Senses       Date:  2020-05-29       Impact factor: 3.160

4.  Conversion of a capture ELISA to a Luminex xMAP assay using a multiplex antibody screening method.

Authors:  Harold N Baker; Robin Murphy; Erica Lopez; Carlos Garcia
Journal:  J Vis Exp       Date:  2012-07-06       Impact factor: 1.355

5.  Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells.

Authors:  Olivier D Defawe; Youyi Fong; Evgenia Vasilyeva; Melissa Pickett; Donald K Carter; Erin Gabriel; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Nicole Frahm; M Juliana McElrath; Stephen C De Rosa
Journal:  J Immunol Methods       Date:  2012-05-22       Impact factor: 2.303

6.  Amniotic fluid metabolomic analysis in spontaneous preterm birth.

Authors:  Ramkumar Menon; Janice Jones; Phillip R Gunst; Marian Kacerovsky; Stephen J Fortunato; George R Saade; Sanmaan Basraon
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

7.  Bead Based Multiplex Assay for Analysis of Tear Cytokine Profiles.

Authors:  Praveen Kumar Balne; Veonice Bijin Au; Louis Tong; Arkasubhra Ghosh; Mukesh Agrawal; John Connolly; Rupesh Agrawal
Journal:  J Vis Exp       Date:  2017-10-13       Impact factor: 1.355

8.  Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition.

Authors:  Jennifer W Bea; Nicole C Wright; Patricia Thompson; Chengcheng Hu; Stefano Guerra; Zhao Chen
Journal:  Clin Chem Lab Med       Date:  2011-03-02       Impact factor: 3.694

Review 9.  Pushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses.

Authors:  Fadi Saade; Stacey Ann Gorski; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

10.  Development and Evaluation of a New Triplex Immunoassay That Detects Group A Streptococcus Antibodies for the Diagnosis of Rheumatic Fever.

Authors:  Alana L Whitcombe; Paulina Hanson-Manful; Susan Jack; Arlo Upton; Polly Atatoa Carr; Deborah A Williamson; Michael G Baker; Thomas Proft; Nicole J Moreland
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.